After a Texas court decided that approval of the abortion pill, mifepristone, was invalid and ordered the drug off the market, an appeals court has decided to temporarily allow access, but is requiring the Food and Drug Administration to restore critical safeguards to chemical abortion drugs while the lawsuit proceeds.
